Search results
What to know about the COVID-19 FLiRT variant as it spreads in Connecticut ahead of summer
The News-Times· 2 days agoA new group of COVID-19 variants called “FLiRT” are rapidly becoming the dominant mutations of the...
Earnings call: Invivyd optimistic about PEMGARDA's market potential
Investing.com· 4 days agoInvivyd is committed to expanding its product offerings and is working on securing reimbursement and...
"FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about...
CBS News· 7 days agoMore than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing...
Long Dismissed, Chronic Lyme Is Finally in the Spotlight
Time via AOL· 19 hours agoFalse negatives are common, especially when people are tested early in their infections, since it...
Rare Blood Clots From J&J, Astra Covid Shots Linked to Genetics
Bloomberg· 2 days agoRare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Plc’s Covid-19 shots were...
There's a new highly transmissible COVID-19 variant. Could FLiRT lead to a summer uptick?
Los Angeles Times· 7 days agoTwo new COVID-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter’s...
There's a new highly transmissible COVID-19 variant: Could FLiRT lead to a summer uptick?
Medical Xpress· 4 days agoTwo new COVID-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter's...
There's a new highly transmissible COVID-19 variant. Could FLiRT lead to a summer uptick?
LA Times via AOL· 7 days agoIn years past, summer travel and gatherings have spurred surges in coronavirus infections. As...
These 2 No-Brainer Growth Stocks Are Breaking New Ground
Motley Fool via Yahoo Finance· 1 day agoAlthough the company's revenue declined by 1% year over year to $3.15 billion in the first quarter,...
Chronic Lyme Disease: Why COVID May Spark Better Tests and Treatment
Well and Good· 2 days agoPeople with chronic Lyme disease (or PTLDS) are understudied and have limited treatment options, but...